Fig. 3From: Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective studyKaplan–Meier curves. Even-free survival curves in the two marched groups of GLP-1RA and BI initiators are shown for the primary composite outcome and its components. The hazard ratio (HR) and 95% CI are reported. Number of patients at risk are also shown for each timepointBack to article page